These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20727962)

  • 1. Developmental pathology, dopamine, stress and schizophrenia.
    Lodge DJ; Grace AA
    Int J Dev Neurosci; 2011 May; 29(3):207-13. PubMed ID: 20727962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress.
    Grace AA
    Neurotox Res; 2010 Nov; 18(3-4):367-76. PubMed ID: 20143199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia.
    Lodge DJ; Grace AA
    Trends Pharmacol Sci; 2011 Sep; 32(9):507-13. PubMed ID: 21700346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.
    Chen L; Perez SM; Lodge DJ
    Dev Neurobiol; 2014 Sep; 74(9):907-17. PubMed ID: 24554310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia.
    Lodge DJ; Grace AA
    J Neurosci; 2007 Oct; 27(42):11424-30. PubMed ID: 17942737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent stress contributes to aberrant dopamine signaling in a heritable rodent model of susceptibility.
    Perez SM; Lodge DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109701. PubMed ID: 31299274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural basis of psychosis-related behaviour in the infection model of schizophrenia.
    Meyer U; Feldon J
    Behav Brain Res; 2009 Dec; 204(2):322-34. PubMed ID: 19154759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis.
    Sonnenschein SF; Grace A
    Expert Opin Ther Targets; 2021 Jan; 25(1):15-26. PubMed ID: 33170748
    [No Abstract]   [Full Text] [Related]  

  • 9. New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways.
    Perez SM; Lodge DJ
    Drug Des Devel Ther; 2014; 8():887-96. PubMed ID: 25061280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia.
    Aguilar DD; Chen L; Lodge DJ
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.
    Lodge DJ; Grace AA
    Neurotox Res; 2008 Oct; 14(2-3):97-104. PubMed ID: 19073417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain.
    Lipska BK; Lerman DN; Khaing ZZ; Weinberger DR
    Eur J Neurosci; 2003 Dec; 18(11):3097-104. PubMed ID: 14656305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
    Schifani C; Hafizi S; Tseng HH; Gerritsen C; Kenk M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Res; 2019 Nov; 213():80-86. PubMed ID: 30409695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Storage, recall, and novelty detection of sequences by the hippocampus: elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine.
    Lisman JE; Otmakhova NA
    Hippocampus; 2001; 11(5):551-68. PubMed ID: 11732708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal nutritional deprivation as a risk factor in schizophrenia: preclinical evidence.
    Butler PD; Susser ES; Brown AS; Kaufmann CA; Gorman JM
    Neuropsychopharmacology; 1994 Dec; 11(4):227-35. PubMed ID: 7857497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice.
    Scott D; Tamminga CA
    Behav Brain Res; 2018 Feb; 339():114-123. PubMed ID: 29155005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia.
    Grace AA
    Neuropharmacology; 2012 Mar; 62(3):1342-8. PubMed ID: 21621548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia.
    Lodge DJ; Grace AA
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):69-76. PubMed ID: 21329556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal neurons in schizophrenia.
    Heckers S; Konradi C
    J Neural Transm (Vienna); 2002 May; 109(5-6):891-905. PubMed ID: 12111476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat.
    Lipska BK; Halim ND; Segal PN; Weinberger DR
    J Neurosci; 2002 Apr; 22(7):2835-42. PubMed ID: 11923448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.